Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
112
Views
9
CrossRef citations to date
0
Altmetric
Review

Checkpoint Inhibitors in Melanoma Patients with Underlying Autoimmune Disease

Hilary Dietz1 Division of Medical Oncology, Duke University, Durham, NC, USAORCID Iconhttps://orcid.org/0000-0001-9586-9902
ORCID Icon,
Sophia C Weinmann2 Division of Rheumatology and Immunology, Duke University, Durham, NC, USA
&
April K Salama1 Division of Medical Oncology, Duke University, Durham, NC, USACorrespondence[email protected]
Pages 8199-8208 | Published online: 02 Nov 2021

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jane E. Rogers, Kohei Yamashita, Matheus Sewastjanow-Silva, Ernesto Rosa Vicentini, Rebecca Waters & Jaffer A. Ajani. (2023) Nivolumab combination therapy as first-line treatments for unresectable, advanced or metastatic esophageal squamous cell carcinoma. Expert Review of Anticancer Therapy 23:6, pages 565-571.
Read now

Articles from other publishers (8)

Bohan Yin, Monika Gosecka, M. Bodaghi, Daniel Crespy, George Youssef, Jagan Mohan Dodda, Siu Hong Dexter Wong, Abu Bin Imran, Mateusz Gosecki, Arjaree Jobdeedamrong, M. Afzali Naniz & A. Zolfagharian. (2024) Engineering multifunctional dynamic hydrogel for biomedical and tissue regenerative applications. Chemical Engineering Journal, pages 150403.
Crossref
YaLing Liu, Dan Li, Yong Chen, YiJuan Liu, YiJuan Lin, XunRu Huang, Ting Wu, ChengDang Wang & Jian Ding. (2023) Integrated bioinformatics analysis for conducting a prognostic model and identifying immunotherapeutic targets in gastric cancer. BMC Bioinformatics 24:1.
Crossref
Bahareh Farasati Far, Dorsa Rabie, Parisa Hemati, Parastoo Fooladpanjeh, Neda Faal Hamedanchi, Nima Broomand Lomer, Arian Karimi Rouzbahani & Mohammad Reza Naimi-Jamal. (2023) Unresectable Hepatocellular Carcinoma: A Review of New Advances with Focus on Targeted Therapy and Immunotherapy. Livers 3:1, pages 121-160.
Crossref
Amanda Reyes, Atish Mohanty, Rebecca Pharaon & Erminia Massarelli. (2022) Association between Immunosuppressive Therapy Utilized in the Treatment of Autoimmune Disease or Transplant and Cancer Progression. Biomedicines 11:1, pages 99.
Crossref
Yasunari Matsuzaka & Ryu Yashiro. (2022) Molecular Docking and Intracellular Translocation of Extracellular Vesicles for Efficient Drug Delivery. International Journal of Molecular Sciences 23:21, pages 12971.
Crossref
Lauren S. Fane, Jimmy T. Efird, Charulata Jindal & Tithi Biswas. (2022) Dermatological Autoimmune Considerations of Immune Checkpoint Therapy. Biomedicines 10:10, pages 2339.
Crossref
Yixuan Yu, Yang Zhou, Xu Zhang, Kexin Tan, Jiabin Zheng, Jia Li & Huijuan Cui. (2022) Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Psoriasis: A Systematic Review and Meta-Analysis of Observational Studies. Frontiers in Oncology 12.
Crossref
Ke Zhang, Xiangyi Kong, Yuan Li, Zhongzhao Wang, Lin Zhang & Lixue Xuan. (2022) PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases. Frontiers in Pharmacology 13.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.